Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

The origins of breast cancer prognostic gene expression profiles.

Lukes L, Crawford NP, Walker R, Hunter KW.

Cancer Res. 2009 Jan 1;69(1):310-8. doi: 10.1158/0008-5472.CAN-08-3520.

2.

Expression signature developed from a complex series of mouse models accurately predicts human breast cancer survival.

He M, Mangiameli DP, Kachala S, Hunter K, Gillespie J, Bian X, Shen HC, Libutti SK.

Clin Cancer Res. 2010 Jan 1;16(1):249-59. doi: 10.1158/1078-0432.CCR-09-1602. Epub 2009 Dec 22.

3.

Metastasis predictive signature profiles pre-exist in normal tissues.

Yang H, Crawford N, Lukes L, Finney R, Lancaster M, Hunter KW.

Clin Exp Metastasis. 2005;22(7):593-603. Epub 2006 Feb 11.

4.

Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease.

Qiu TH, Chandramouli GV, Hunter KW, Alkharouf NW, Green JE, Liu ET.

Cancer Res. 2004 Sep 1;64(17):5973-81.

5.

A mouse mammary gland involution mRNA signature identifies biological pathways potentially associated with breast cancer metastasis.

Stein T, Salomonis N, Nuyten DS, van de Vijver MJ, Gusterson BA.

J Mammary Gland Biol Neoplasia. 2009 Jun;14(2):99-116. doi: 10.1007/s10911-009-9120-1. Epub 2009 Apr 30. Review. Erratum in: J Mammary Gland Biol Neoplasia. 2009 Jun;14(2):117-9.

PMID:
19408105
6.

Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage.

Zhu M, Yi M, Kim CH, Deng C, Li Y, Medina D, Stephens RM, Green JE.

Genome Biol. 2011 Aug 16;12(8):R77. doi: 10.1186/gb-2011-12-8-r77.

7.

The α₂β₁ integrin is a metastasis suppressor in mouse models and human cancer.

Ramirez NE, Zhang Z, Madamanchi A, Boyd KL, O'Rear LD, Nashabi A, Li Z, Dupont WD, Zijlstra A, Zutter MM.

J Clin Invest. 2011 Jan;121(1):226-37. doi: 10.1172/JCI42328. Epub 2010 Dec 6.

8.

Invading basement membrane matrix is sufficient for MDA-MB-231 breast cancer cells to develop a stable in vivo metastatic phenotype.

Abdelkarim M, Vintonenko N, Starzec A, Robles A, Aubert J, Martin ML, Mourah S, Podgorniak MP, Rodrigues-Ferreira S, Nahmias C, Couraud PO, Doliger C, Sainte-Catherine O, Peyri N, Chen L, Mariau J, Etienne M, Perret GY, Crepin M, Poyet JL, Khatib AM, Di Benedetto M.

PLoS One. 2011;6(8):e23334. doi: 10.1371/journal.pone.0023334. Epub 2011 Aug 15.

9.

Comparing genetically engineered mouse mammary cancer models with human breast cancer by expression profiling.

Shoushtari AN, Michalowska AM, Green JE.

Breast Dis. 2007;28:39-51. Review.

PMID:
18057542
10.

In silico ascription of gene expression differences to tumor and stromal cells in a model to study impact on breast cancer outcome.

Myhre S, Mohammed H, Tramm T, Alsner J, Finak G, Park M, Overgaard J, Børresen-Dale AL, Frigessi A, Sørlie T.

PLoS One. 2010 Nov 19;5(11):e14002. doi: 10.1371/journal.pone.0014002.

11.

S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways.

Nasser MW, Qamri Z, Deol YS, Ravi J, Powell CA, Trikha P, Schwendener RA, Bai XF, Shilo K, Zou X, Leone G, Wolf R, Yuspa SH, Ganju RK.

Cancer Res. 2012 Feb 1;72(3):604-15. doi: 10.1158/0008-5472.CAN-11-0669. Epub 2011 Dec 12.

12.
13.

HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis.

Sun M, Song CX, Huang H, Frankenberger CA, Sankarasharma D, Gomes S, Chen P, Chen J, Chada KK, He C, Rosner MR.

Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9920-5. doi: 10.1073/pnas.1305172110. Epub 2013 May 28.

14.

Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers.

Wendt MK, Taylor MA, Schiemann BJ, Sossey-Alaoui K, Schiemann WP.

Breast Cancer Res. 2014 Mar 11;16(2):R24. doi: 10.1186/bcr3623.

15.

Next generation sequencing-based expression profiling identifies signatures from benign stromal proliferations that define stromal components of breast cancer.

Guo X, Zhu SX, Brunner AL, van de Rijn M, West RB.

Breast Cancer Res. 2013 Dec 17;15(6):R117. doi: 10.1186/bcr3586.

16.

Tumour but not stromal expression of β3 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer.

Carter RZ, Micocci KC, Natoli A, Redvers RP, Paquet-Fifield S, Martin AC, Denoyer D, Ling X, Kim SH, Tomasin R, Selistre-de-Araújo H, Anderson RL, Pouliot N.

J Pathol. 2015 Apr;235(5):760-72. doi: 10.1002/path.4490. Epub 2015 Jan 7.

PMID:
25430721
17.

Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.

Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z, Rasmussen KE, Jones LP, Assefnia S, Chandrasekharan S, Backlund MG, Yin Y, Khramtsov AI, Bastein R, Quackenbush J, Glazer RI, Brown PH, Green JE, Kopelovich L, Furth PA, Palazzo JP, Olopade OI, Bernard PS, Churchill GA, Van Dyke T, Perou CM.

Genome Biol. 2007;8(5):R76.

18.

MicroRNA profiling of the pubertal mouse mammary gland identifies miR-184 as a candidate breast tumour suppressor gene.

Phua YW, Nguyen A, Roden DL, Elsworth B, Deng N, Nikolic I, Yang J, Mcfarland A, Russell R, Kaplan W, Cowley MJ, Nair R, Zotenko E, O'Toole S, Tan SX, James DE, Clark SJ, Kouros-Mehr H, Swarbrick A.

Breast Cancer Res. 2015 Jun 13;17:83. doi: 10.1186/s13058-015-0593-0.

19.

[microRNA expression in breast development and breast cancer].

Avril S.

Pathologe. 2013 Nov;34 Suppl 2:195-200. doi: 10.1007/s00292-013-1878-7. Review. German.

PMID:
24196612
20.

Simultaneous analysis of tumor and stromal gene expression profiles from xenograft models.

Iorns E, Clarke J, Ward T, Dean S, Lippman M.

Breast Cancer Res Treat. 2012 Jan;131(1):321-4. doi: 10.1007/s10549-011-1784-8. Epub 2011 Sep 24.

PMID:
21947683

Supplemental Content

Support Center